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Abstract: Transport of representative neutral a-amino 
acids was measured in brain slices after injecting thy- 
roxine into donor rats of various ages from 1 to 23 days 
old. The hormone did not alter uptake in slices from 1- 
day-old rats even when treatment was begun on pregnant 
rats as much as 10 days before delivery. Injecting thy- 
roxine until age 6 days, however, decreased the activity 
of transport system A (the major sodium-dependent 
system in most mammalian cells) and caused appearance 
of a new transport system used by the model amino acids, 
2-aminoisobutyric acid and 2-(methy1amino)isobutyric 
acid. Uptake at 6 days was similar to that found in slices 
from older, untreated rats (e.g., those 14 days old). These 
A thyroid hormone deficiency during develop- 
ment of the brain of an animal can impair the growth 
and maturation of the central nervous system and 
produce irreversible mental retardation (Eayrs, 
1961). Growth and development involve many met- 
abolic events, including synthesis of new protein, 
and protein synthesis is one of the processes stim- 
ulated by thyroid hormones (Gelber et al., 1964; 
Gee1 et al., 1967). In addition, these hormones in- 
crease transport of at least some amino acids into 
tissues, including transport into rat brain in vivo 
(Daniel et al., 1975). The elevated uptake would be 
necessary to supply the amino acids required intra- 
cellularly for net synthesis of protein. Changes in 
amino acid transport would, therefore, be expected 
in response to thyroid hormone during the period 
of rapid brain development. 
In the first paper in this series (Riggs et al., 1984), 
we have described some of the changes in neutral 
a-amino acid transport systems that occur in rat 
brain over the first 3 weeks after birth. It is over 
results strongly suggest that one action of thyroxine is to 
accelerate the development of neutral a-amino acid trans- 
port systems of brain over the first six days after birth. 
Thyroxine treatment of rats from birth to age 14 days also 
appears to increase the activities of both system A and 
the second transport system used by the two model amino 
acids in brains from 14-day-old rats. Key Words: Brain- 
Transport systems - Thyroxine - Amino acids - Devel- 
opment-Rats. Riggs T. R. et al. Thyroxine-induced 
changes in the development of neutral a-amino acid trans- 
port systems of rat brain. J .  Neurochem. 42, 1260-1268 
( 1984). 
this period that the major development of the rat 
brain takes place (Dobbing, 1971). This is also the 
time during which thyroid hormone is required for 
brain development in the rat (Hamburgh et al., 
1964). In the present paper, we show the effects of 
thyroxine on transport of neutral a-amino acids into 
brain slices from rats aged 1-23 days and describe 
some of the changes that occur in their transport 
systems in response to thyroxine. 
MATERIALS AND METHODS 
Procedures were similar to those reported earlier 
(Riggs et al., 1984). Newborn rats (Sprague-Dawley or- 
igin) were maintained with their mothers in groups of 8- 
10 pups each. Animals were grouped at random into five 
age ranges for most studies: 1-day group, rats from birth 
up to 24 h old; 6-day group, rats 5-7 days old; 10-day 
group, those 10 or 11 days old; 14-day group, those 13- 
15 days old; and 23-day group, those 22-24 days old. 
To produce hyperthyroidism, one group of pups was 
injected subcutaneously with 0.1 ml of thyroxine penta- 
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hydrate in 0.9% NaCl solution alkalinized with 0.01 M 
sodium phosphate buffer medium, pH 10. Some control 
animals received the alkalinized saline solution alone; 
however, some pups did not receive injections, since the 
same results were obtained. In the initial experiments, 
thyroxine was given according to the dosage schedule 
used by Hamburgh et  al. (1964): pups aged 0-7 days re- 
ceived 0.5 pglday; those 8- 14 days got 1 .O pglday; those 
15-21 days, 1.5 pglday; and those 22-30 days, 2 pglday. 
For later experiments, animals 0-9 days old received 1 
pg of thyroxine every other day, and those 10 days and 
older got 2 pg every other day. No differences in results 
were found between the two treatment schedules. 
Two additional groups of rats were studied in the early 
experiments: one group in which pregnant rats and 
mothers received 0.1% propylthiouracil (PTU) in their 
drinking water throughout the entire experimental period 
(hypothyroid), and another group that received both the 
PTU and thyroxine injections. 
Brain slices 0.4 mm thick were prepared from cerebral 
hemispheres with a McIlwain tissue chopper. They were 
incubated then in most cases in Krebs-Ringer bicarbonate 
medium containing 10 mM glucose and 14C-labeled amino 
acid, with continuous gassing with 95% 02-5% CO,. 
Studies on inhibition of uptake and other experimental 
details were the same as described previously (Riggs et 
al., 1984). All [l4C]arnino acid levels in brain were cal- 
culated for intracellular water with the values for water 
distribution and space reported earlier for control and 
thyroxine-treated rats at each age (Riggs et al., 1984). 
Some results are expressed as distribution ratio, which is 
the ratio of level of [14C]amino acid in intracellular water 
to that in incubation medium. 
RESULTS 
Effect of thyroxine treatment in vivo on transport 
of amino acids into brain slices from rats of 
different ages 
Injecting donor rats with thyroxine from birth re- 
sulted in significant decreases in uptakes of both 2- 
aminoisobutyric acid (AIB) and alanine in tissues 
at day 6 (Figs. 1 and 2). A more detailed study with 
AIB showed this effect at all levels less than about 
15 mM (see discussion of Fig. 4, below). With 2- 
(met hy1amino)isobutyric acid (Me AIB) , hormone 
pretreatment gave a stimulation of uptake with 0.5- 
1 mM levels of the amino acid (Fig. 2), but gave 
only inhibition at higher levels. This difference ap- 
pears to be a result of a thyroxine-induced change 
in the kinetics of uptake of this amino acid (see 
discussion of Fig. 3). 
No effect of thyroxine treatment was found on 
AIB uptake at 1 or 3 days; but cycloleucine uptake 
(1 mM, 30 min incubation) was elevated by hor- 
mone treatment for 3-4 days (distribution ratios of 
11.63 I~ I  0.58 for six samples in controls and 13.25 
_+ 0.38 for eight samples after hormone treatment; 
p < 0.05). At 10 and 14 days, uptakes of 1 mM 
levels of both AIB and MeAIB were stimulated by  
the hormone (Figs. 1 and 2). Alanine transport was 
R g e  i n  D a y s  
FIG. 1. Effects of thyroxine and PTU on uptake of AIB by 
brain slices from rats of different ages. Uptake of 1 m M  
[14C]AIB was measured for 30 rnin in normal Krebs-Ringer 
bicarbonate medium. Thyroxine and PTU treatments were as 
given in Materials and Methods. Values are averages * SEM 
for 4-29 samples per group. The vertical bars represent one 
standard error on each side of the average value. 0,  control; 
X, thyroxine-treated; A, PTU-treated. Statistical comparisons, 
thyroxine- or PTU-treated versus control: ap < 0.05; bp < 
0.01 ; cp < 0.001. 
increased at 22 days when a 1 mM level of the 
amino acid was used, although the stimulation was 
not statistically significant with a 0.5 mM level (Fig. 
2). The data of Fig. 1 show that uptake of AIB in 
the hormone-treated tissues remained fairly con- 
stant from 6 to 30 days of age except for a drop at 
23 days. Since transport into control tissues de- 
creased after 6 days, the net effect was a statisti- 
cally significant stimulation of AIB uptake at the 
ages studied beyond 6 days (Fig. 1). 
Treatment of donor rats with PTU resulted in 
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FIG. 2. Effect of thyroxine on uptakes of MeAlB and alanine 
by brain slices from rats of different ages. Uptakes of 0.5 mM 
alanine (0, 0)  or 1 mM MeAlB (A, A) were measured for 30 
min in normal Krebs-Ringer bicarbonate medium. Thyroxine 
treatment was as described in Materials and Methods. 0 and 
A, controls; 0 and A, thyroxine-treated. Values are averages 
of 6-25 samples +- SEM for MeAlB and of 10-44 values each 
for alanine. The vertical lines represent one standard error 
around the average. Statistical comparisons, thyroxine- 
treated versus controls: ap < 0.05, bp < 0.001, 
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(Fig. 1). Thyroxine treatment of the rats given PTU 
resulted in uptake values similar to or higher than 
those produced by the hormone alone (distribution 
ratios of 25-27 at ages of 6-16 days). 
Thyroxine treatment of donor rats also increased 
the uptake of 1 mM leucine by slices from 14-day- 
old rats by 16% in a 30 min incubation (p < 0.05). 
No significant effect was found in tissues from 6- 
or 23-day-old rats. 
Effects of length of treatment with thyroxine on 
AIB uptake by slices from rats of different ages 
As noted above, in all of the foregoing tests of 
thyroxine treatment, the hormone was given from 
birth until the animals were used, so that length of 
treatment was different for each age group. Exper- 
iments were, therefore, carried out to determine if 
age of the donor rat or length of thyroxine treatment 
was more directly related to the lack of response of 
AIB uptake in 1 day tissues and the apparent 
change from inhibition to stimulation in going from 
6- to 10-day-old brain. The results of Table 1, lines 
1-6, show that thyroxine did not alter AIB uptake 
in slices from either 1- to 3-day rats even when 
treatment began up to 10 days before pups were 
born (by injection into pregnant rats). Furthermore, 
the longer the hormone treatment, the greater the 
inhibitory effect by 6 days and the greater the stim- 
ulation in tissues at 10, 14, or 23 days old (Table 1). 
The inhibition of uptake in the 6-day tissues was 
not changed to stimulation by 10 days on the hor- 
mone, even though this length of treatment gave 
stimulation in 10-day old tissues. Likewise, the 
slices from 10-day-old rats showed stimulation of 
uptake after 6 days on thyroxine and not the inhi- 
bition shown by tissue from 6-day-old rats given the 
hormone for 6 days. 
Triiodothyronine also failed to produce stimula- 
tion of AIB transport by brain slices from rats less 
than 3 days old. Injection of 5 Fg/rat (0.8 mg/kg 
body weight) of this compound 2 days before sac- 
rifice was without effect on uptake. A 10 p.M level 
of this form of the hormone added in vitro did in- 
crease uptake of 0.05 mM cycloleucine in 3-day tis- 
sues in a 3 h incubation (distribution ratios of 23.2 
k 0.6 versus 27.0 t 1.26, p < 0.05, for six samples 
in each group). A 3 or 4 h period of preincubation 
with 10 or 40 F M  triiodothyronine did not alter up- 
take of 0.05 mM AIB by brain slices from 1- or 4- 
day-old rats, however. Shorter times of exposure to 
either form of the hormone in vitro were uniformly 
without effect in altering transport of either of these 
amino acids. 
Identification of the brain transport system@) 
altered by thyroxine 
The changes in effects of thyroxine on amino acid 
uptakes with aging strongly suggest that the hor- 
mone alters their transport systems in brain over 
TABLE 1. The effect of time of treatment with 
thyroxine on transport of AZB into brain slices from 
rats of different ages 
~~ ~ 
Age in Days on p versus no 
days thyroxine Distribution ratio thyroxine 
I 0 10.45 t 0.85 (4) 
6" 11.80 t 0.11 (6) 
8-lob 10.09 t 0.27 (16) 
3 0 15.78 2 0.35 (4) 
3 15.89 t 0.80 (11) 
13c 14.66 2 0.82 (3) 
6 0 24.57 t 0.87 (29) 
6 21.66 t 0.62 (28) 
1 1 c  17.34 t 0.26 (7) 
10 0 17.42 t 0.56 (19) 
6 19.86 5 0.49 (8) 
10 22.10 -+ 1.20 (18) 
14 0 19.05 t 1.00 (18) 
'14 18.26 2 0.56 (6) 
6 21.45 2 1.22 (8) 
10 22.03 2 0.99 (6) 
14 24.51 +. 0.87 (23) 
23 0 16.69 2 0.37 (25) 
14 17.96 2 0.78 (14) 
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The hormone was injected subcutaneously into pregnant rats 
and/or their pups for the lengths of time shown. Pups aged 1- 
14 days were given 1 pg of thyroxine every other day, whereas 
those older than 14 days were given 2 pg every other day. 
Amounts of thyroxine injected into pregnant rats are given 
below. AIB uptake was measured for '/2 h at a 1 mMlevel. Values 
given are averages of distribution ratios t SE for the number 
of samples in the parentheses. 
a Mothers received 50 pglday for 6 days. 
Mothers received 25 pg/day for 8-10 days. 
Mothers received 25 pglday, then pups received 1 pg every 
n.s. = not significant (p > 0.05) 
other day. 
the period 1-14 days. We, therefore, used AIB and 
MeAIB to characterize these changes, since trans- 
ports of these amino acids were highly sensitive to 
thyroxine. The same two types of experiments were 
used as described earlier for brains from normal 
rats: the effects of inhibitory conditions on trans- 
port and analysis of kinetics of transport (Riggs et 
al., 1984). Our preliminary studies showed that var- 
ious inhibitory agents and conditions produced 
much the same patterns of inhibition in brains from 
the thyroxine-treated rats as in those from control 
animals. Such a result is not unexpected, since the 
change in transport produced by the hormone 
amounted to only one-third or less of the total up- 
take; the total characteristics of the transport sys- 
tems were, therefore, mostly those of the controls. 
A more exact characterization of the transport 
system(s) altered by the hormone was made, there- 
fore, by evaluating that portion of the uptake that 
was lost at 6 days or gained at 10-14 days, a quan- 
tity that could be obtained by taking the arithmetic 
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difference between the two uptakes (hormone- 
treated minus control) under the same incubation 
conditions. Since these differences are measures of 
the transport modified by thyroxine, their charac- 
teristics will show what transport system(s) are al- 
tered by the hormone. 
Thyroxine-induced changes in amino acid 
transport systems in brain slices from 
6-day-old rats 
Although thyroxine stimulated the uptake of a 1 
mM level of MeAIB in a 30 min incubation (Fig. 2), 
five out of seven inhibitory conditions (including 10 
mM MeAIB) brought the values in the hormone- 
treated tissues significantly below those found in 
their controls (Table 2, column 3 versus column 2). 
One of the two other inhibitors, 10 mM leucine, also 
gave a lower value after thyroxine treatment, but 
the change was not significant statistically. Only 
with 10 mM AIB or in the absence of any inhibitor 
was uptake higher after thyroxine treatment than in 
control tissues (Table 2). 
These results suggest that the effect of thyroxine 
on MeAIB uptake in slices of 6-day-old rats de- 
pended on the total level of amino acids present that 
used the same transport systems as MeAIB, 
changing from stimulation to inhibition as the load 
increased. This explanation is confirmed by com- 
paring the uptakes of different levels of MeAIB in 
slices from control and thyroxine-treated rats. 
Figure 3 shows a reciprocal (Lineweaver-Burk) plot 
of saturable uptake of MeAIB in the thyroxine- 
treated tissues of this age (the solid lines). The 
1 "  t 
FIG. 3. Reciprocal (Lineweaver-Burk) plot of MeAlB uptake 
in brain slices from 6-day-old thyroxine-treated rats. MeAlB 
was at 0.1 to 30 mM, and incubation time was 10 min. Non- 
saturable entry (0.12/10 min) was calculated by the method 
of Akedo and Christensen (1962) and subtracted from total 
uptake to give saturable uptake (vo). The solid lines were 
calculated by the method of least squares to fit the points 
shown for uptake in the thyroxine-treated tissues. The 
dashed line represents the uptake of MeAlB under the same 
conditions in brain slices from 6-day-old control rats (not 
treated with hormone) (points omitted here for clarity). The 
two solid lines are significantly different from each other in 
both slope (p < 0.02) and intercept on the ordinate (p < 
0,001). Two values were averaged for each point shown. 
dashed line in this figure represents the uptake in 
control 6-day tissues (Riggs et al., 1984); the points 
are omitted for clarity. A comparison of the control 
(dashed) line with that after hormone treatment 
(solid lines) shows that thyroxine stimulated 
MeAIB uptake at levels below about 0.5 mM and 
inhibited it at higher levels. Such a result can be 
explained by an alteration of the kinetics of uptake, 
as is readily apparent from the different slopes and 
y intercepts of the solid lines versus the dashed line 
of Fig. 3. 
The thyroxine-induced change, however, is not 
explained entirely as due to a change in kinetics of 
MeAIB transport by way of system A, the single 
system it uses in the 6-day control tissues (Riggs et 
al., 1984). Figure 3 shows a nonlinear uptake after 
hormone treatment, evidence for which is given by 
calculation from the points of two lines with signif- 
icantly different slopes and y intercepts. The thy- 
roxine, therefore, appears to have induced forma- 
tion of a second transport system used by MeAIB 
in the 6-day tissue. The appearance of this new 
system can account in part for the change in ki- 
netics of the uptake. 
Figure 4 shows that AIB also was transported by 
more than one system in slices from thyroxine- 
treated 6-day-old rats, although it also used only 
one system in the control brains (Riggs et al., 1984). 
The results also demonstrate that, in contrast to 
uptake of MeAIB, the uptake of AIB was lower 
than normal in the hormone-treated tissues at all 
levels below about 15 mM, but the same, or perhaps 
higher than normal, at levels above 15 mM. 
The appearance of a thyroxine-induced, second 
system at 6 days was shown also by comparing the 
characteristics of AIB and MeAIB uptakes after 
thyroxine treatment' with those of the transport lost 
due to thyroxine. With MeAIB, all inhibitors tested 
gave a significantly greater effect on one of these 
measurements than on the other one (Table 2, col- 
umns 5-7), while with AIB, statistically significant 
deviations were given by six of the 14 inhibitors 
tested (Fig. 5 ) .  Most striking with this latter amino 
acid were the effects of phenylalanine, leucine, and 
glycine, which inhibited total uptake in the hor- 
mone-treated tissues by about 60-70% without al- 
tering the decrement, or perhaps stimulating it 
somewhat (Fig. 5) .  
The inhibition studies, therefore, show again that 
the two test amino acids are not transported to the 
The comparison was made with values after the thyroxine 
treatment, rather than with controls, since transport was de- 
creased due to the hormone. That portion of the transport lost 
due to thyroxine is included in the controls, but is not present 
after hormone treatment. The most significant comparison, 
therefore, is that of the characteristics of the transport system($ 
changed by thyroxine (i.e., lost) versus those that remain after 
the loss. 
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TABLE 2. Inhibition of transport of' MeAZB into brain slices from 6-day-old ruts with and without 
prior thyroxine treatment 
Saturable entry" in: % Inhibition of saturable entry for: 
Change 
due to 
Inhibitor Control Th yroxine-treated P Thyroxine-treatedd thyroxinee P 
- - 13.23 t 0.68 15.01 f 0.55 <0.05 - None 
Incubate at 18°C 0.14 2 0.07 -0.45 f 0.17 <0.01 103 t 1.1 133 2 9.5' <0.02 
pH 5.4 (Pi buffer) 8.57 f 0.37 5.74 f 0.31 <0.001 62 t 2.1 259 2 eo.001 
10 mM AIB 2.97 5 0.15 4.30 I? 0.19 <0.001 71 2 1.3 25 f 11 <0.01 
10 mM MeAIB 4.43 2 0.48 2.33 f 0.32 <0.02 84 f 2.1 218 2 18' <0.001 
10 mM Leucine 10.73 f 0.62 8.78 f 0.45 n.s.b 42 2 3.0 209 f 25c <0.001 
10 mM Phenylalanine 10.47 2 0.33 5.07 2 0.37 <0.001 66 f 2.4 404 f 21c <0.001 
10 mM Valine 10.57 2 0.36 6.15 f 0.39 <0.001 59 t 2.6 349 f 22c eo.001 
Tissues were incubated 30 min with 1 mM MeAIB with the condition or addition shown in column 1. Values in columns 2 and 3 are 
saturable uptakes, obtained by subtracting nonsaturable entry from total uptake. Nonsaturable entry was found to be 0.1 1 and 0.36/30 
min in control and hormone-treated tissues, respectively, as determined by the method of Akedo and Christensen (1962). The numbers 
are averages of 5- 17 values 2 SEM in each case. 
pmol/ml cellular water/30 min 
* n.s. = not significant (p > 0.05) 
Inhibition significantly greater than 100% (p < 0.02 to p < 0.001) 
[Entry in presence of inhibitor (column 3) X 100]/[Entry in absence of inhibitor (column 3, line l)] 
[Difference between columns 2 and 3 X 100]/[Difference between columns 2 and 3,  line 11 
same extent by the same systems in the controls 
compared with the thyroxine-treated tissues. They 
are thus consistent with the kinetic data discussed 
above, suggesting appearance of a second transport 
system used by both AIB and MeAIB in brain slices 
from the 6-day-old thyroxine-treated rats. 
FIG. 4. Reciprocal (Lineweaver-Burk) plot of AIB uptake in 
brain slices from 6-day-old thyroxine-treated rats. AIB was at 
0.1 to 50 mM and incubation time was 10 min. The solid lines 
were calculated as best fits to the points shown, as described 
in the legend to Fig. 3. Nonsaturable entry was 0.07/10 rnin. 
The dashed line (points omitted) represents AIB uptake in 
control slices from 6-day-old rats, and is taken from Riggs 
et al. (1984). The two solid lines are significantly different 
from each other in both slope and intercept on the ordinate 
(p < 0.001 in both cases). Two to four values were averaged 
for each point shown. 
Thyroxine-induced changes in transport systems 
in brain slices from 14-day-old rats 
Thyroxine treatment for 14 days resulted in stim- 
ulation of transports of MeAIB, AIB, and leucine 
(see above). Inhibition studies with the first two 
amino acids showed that the additional uptake pro- 
duced by thyroxine was probably completely Na+ - 
dependent and highly temperature-sensitive (Table 
3, columns 3 and 6). Strong inhibition of the incre- 
ment was given also by 10 mMAIB, alanine, serine, 
cycloleucine, or glycine. With AIB, six of the 15 
conditions tested showed significantly less inhibi- 
tion of the increment than of the total saturable up- 
take in the controls (compare columns 2 and 3 of 
Table 3 ,  and see the p values in column 4). For 
MeAIB uptake, in contrast, inhibition of the thy- 
roxine stimulation was greater than inhibition of 
total saturable uptake in all but two of the condi- 
tions tested (i.e., in the presence of leucine or va- 
line) (Table 3, column 5 versus column 6, with p 
values in column 7 ) .  These results show that the 
increment in uptake produced by the hormone had 
different characteristics than did the uptake of these 
amino acids in tissues from rats not treated with 
thyroxine. 
Reciprocal plots of uptakes of different levels of 
AIB and MeAIB at 14 days gave nonlinear curves 
after hormone treatment, as was also found for con- 
trol tissues (Riggs et al., 1984). The position of the 
best-fitting line for the low K ,  system was markedly 
below the corresponding control (shown in Fig. 6 
for AIB), a change that shows again the stimulation 
of uptakes of low levels of these amino acids in 
response to the thyroxine. The stimulation was 
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FIG. 5. Effects of inhibitory conditions on uptake of AIB in 
brain slices from 6-day-old thyroxine (T,)-treated rats com- 
pared with effects on the thyroxine-induced change in up- 
take produced by the hormone. The various conditions and 
agents were used as inhibitors of uptake of 1 mM AIB in 30 
min incubations in brain slices from control and thyroxine- 
treated rats. The change in uptake due to hormone treatment 
was calculated under each condition by subtracting satu- 
rable uptake (hormone-treated) from saturable uptake (con- 
trol); these values then were expressed as percent inhibition 
relative to thyroxine-induced change in uptake found in the 
absence of inhibitor (See Table 2, footnote e). The results 
are shown on the ordinate. The abscissa records the percent 
inhibition produced when the slices from the thyroxine- 
treated rats were incubated under each condition (see Table 
2, footnote d). Nonsaturable entry (0.05/10 min for controls, 
0.07/10 min after thyroxine treatment) was subtracted from 
the total uptake in each case to obtain the saturable entry 
used in the calculation, Four to 29 values were averaged to 
obtain the number used for calculating each point shown. 
The inhibitor symbols used are: -Na+, Na*-free incubation 
medium; 18"C, incubation carried out at this temperature; 
pH 5.4, incubated in phosphate buffer at this pH; Sar, 10 mM 
sarcosine; Cycloleu, 10 mM cycloleucine. Other symbols are 
standard abbreviations for amino acids or are as previously 
defined. Each inhibitor amino acid was at a 10 mM level. The 
dashed line shows where the points would fall if the inhibi- 
tory conditions produced the same quantitative effect on 
each of the two measurements. Statistically significant dif- 
ferences were found at 18"C, and in the presence of serine, 
glycine, leucine, isoleucine, or phenylalanine. 
greatest below about 5 mM but was more difficult 
to demonstrate at high levels of either amino acid 
because of the small change relative to the large 
total uptake. 
Kinetics of AIB uptake in brain slices from 
1-day-old thyroxine-treated rats 
Although the hormone did not alter transport of 
a 1 mM level of AIB in 1-day tissues, the above 
results suggested that an effect might be found if 
the proper amino acid level was used. Ten minute 
uptakes were measured, therefore, in thyroxine- 
treated 1-day-old tissues at AIB levels of 0.2-40 
mM and the results compared with those from con- 
trol tissues studied in this same way and reported 
earlier (Riggs et a]., 1984). Reciprocal plots, 1/ 
[AIB], versus l/v,,, showed two significantly dif- 
ferent lines in the hormone-treated tissues, as they 
did in controls, and the saturable uptakes were es- 
sentially the same in control and hormone-treated 
tissues at all AIB levels tested. They failed, there- 
fore, to show any effect of thyroxine on uptake at 
any of the levels used for this amino acid in 1-day 
tissues. The results also confirmed the presence of 
at least two transport systems used by AIB at this 
age. 
DISCUSSION 
Brain slices from rats of different ages showed 
quite different sensitivities of their transports to 
thyroxine treatment. No response could be found 
in 1-day-old tissues even when thyroxine treatment 
began as much as 10 days earlier by injecting the 
hormone into pregnant rats. An inhibition was 
found in 6-day tissues at most physiological amino 
acid loads (see further discussion below), while 
stimulation was produced in tissues 10 days or 
older. Treating donor rats with thyroxine for dif- 
ferent lengths of time modified only the amount of 
inhibition or stimulation of AIB uptake but did not 
change the type of effect (Table 1). The results sug- 
gest that the response to the hormone is character- 
istic of each age and, therefore, that the transport 
systems used by AIB are different at 1 day than at 
6 days and different again at ages beyond 6 days. 
Not only was AIB transport different after thy- 
roxine was injected, but it was decreased markedly 
when donor rats were given the anti-thyroid agent, 
PTU (Fig. 1). At 6 days, both the hormone and PTU 
inhibited AIB uptake, but PTU had a much greater 
effect. Since the control rats still had their endog- 
enous thyroid hormones, the magnitude of the dif- 
ference in AIB uptake due to thyroxine is shown 
best by comparing the results after PTU treatment 
with those after thyroxine treatment. On this basis, 
it can be seen from Fig. 1 that the hormone pro- 
duced a 50-70% increase in uptake at all ages 
studied with PTU, including at 6 days. The PTU 
results show that thyroid hormone is necessary for 
the normal development of neutral a-amino acid 
transport systems in the developing rat brain, since 
uptake in tissues from PTU-treated rats never 
reached levels much above those found at 1 day 
(Fig. 1). 
A more detailed analysis showed that pretreat- 
ment of donor rats with thyroxine changed the 
transport systems used by AIB and MeAIB at both 
6 and 14 days, modifying the changes that occur 
normally during development. In the 6-day-old tis- 
sues, the hormone led to use of a second system in 
addition to the single system, system A, used nor- 
mally by these amino acids at this age. This con- 
clusion is based primarily on two types of evidence 
found for both amino acids: the different inhibition 
characteristics of that part of their uptakes altered 
by the hormone compared with those found in the 
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TABLE 3 .  Inhibition of transports of AZB and MeAZB into brain slices of 14-day-old 
rats with and without thyroxine treatment 
% Inhibition of saturable entry of 
Na+-free medium 
Incubate at  18°C 
pH 5.4 (Pi buffer) 
10 mM AIB 
10 mM MeAIB 
10 mM Alanine 
10 mM Serine 
10 mM Proline 
10 mM Cycloleucine 
10 mM Glycine 
10 mM Sarcosine 
10 mM Leucine 
10 mM Isoleucine 
10 mM Valine 
10 mM Phenylalanine 




91 2 0.6 93 ? 2.8 
81 ? 0.8 68 2 3.0 
33 f 1 . 1  53 f 12 
82 -r- 1.7 71 ? 20 
52 i 4.8" - 1 3  f 11' 
81 2 2.7 89 ? 4.6 
83 2 2.5 72 ? 3.7 
64 rt 3.5 34 2 12 
83 i 0.4 84 i 3.2 
72 ? 0.7 75 2 2.0 
51 2 2.2 44 f 5 .3  
58 ? 1.0 50 2 8.4 
69 t 2.2 31 i 5.4 
63 2 2.4 58 f 17 




















97 ? 0.6 
97 f 1.5 
36 rt 4.4 
48 2 7.1 
61 t 1.5 
65 * 2.2 
- 
- 
38 f 3.8 
59 f 1.9 
18 f 1.6 
- 
109 f 2.6 
110 ? 2.4 
86 9.0 
89 2 6.2 
80 f 3.4 
80 ? 3.2 
- 
- 
44 2 18 
16 f 1 1  












General conditions were as described in the legend to Table 2. Amino acid was at a I mM level; 
incubation time was 30 min for MeAIB and an average of values from 30 and 60 min incubations for 
AIB. Values are calculated for saturable entry; nonsaturable entry was 0.39 and 0.21/30 min for AIB 
in control and hormone-treated tissues, respectively, and 0.44 and 0.29/30 min for MeAIB in control 
and hormone-treated tissues, respectively. Values are averages 2 SEM for 6-45 samples each for 
AIB, and 6-14 samples each for MeAIB. 
See Table 2, footnote e ,  for method of calculation. 
n.s. = not significant statistically (p > 0.05). 
20 mM MeAIB used. 
0 2 I 4 6 8 10 12 
1 / ( R I B l p  
FIG. 6. Reciprocal (Lineweaver-Burk) plot of AIB uptake in 
brain slices from 14-day-old thyroxine-treated rats. AIB was 
at 0.1 to 60 mM and incubation time was 10 min. The solid 
lines were calculated as best fits to the points as described 
in the legend to Fig. 3. Nonsaturable entry was 0.05/10 min. 
The dashed lines (points omitted) represent AIB uptake in 
control slices from 14-day-old rats and is taken from Riggs 
et al. (1984). The two solid lines are significantly different 
from each other in both slope (p < 0.001) and intercept on 
the ordinate (p < 0.05). Two to eight values were averaged 
for each point shown. 
thyroxine-treated tissues, and the presence of non- 
linear reciprocal kinetic plots for uptakes in the hor- 
mone-treated tissues compared with single linear 
plots in the controls. The kinetic changes were such 
that uptakes of both amino acids were decreased at 
some levels and not changed or increased at other 
levels (Figs. 3 and 4). AIB, MeAIB, and alanine all 
showed less uptake after thyroxine treatment when 
their levels approximated the total physiological 
blood load of amino acids that use the same systems 
they do, i.e., around 1-2 mM. A decreased uptake, 
occurring at the same time that a second system 
became functional, shows that the normal, highly 
active 6-day system A was disappearing at the same 
time that a less active system was being formed. 
The decreased use of system A was greater than 
shown by the decrement in uptake, however, be- 
cause of the appearance and use of the new system. 
The changes induced by thyroxine at 6 days pro- 
duced transports similar to those found in normal 
brain slices taken from donor rats as they aged be- 
yond 6 days, i.e., a decrease in uptake of AIB and 
MeAIB by system A accompanied by the appear- 
ance of a second system (Riggs et al., 1984). In 
addition, treatment with thyroxine for 11 days 
(begun by injecting the hormone into pregnant rats) 
led to an even greater decrease in AIB uptake in 6- 
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day slices than found after treatment for 6 days 
(Table l), an indication that transitional develop- 
ment of the transport systems had gone even further 
in these 6-day postnatal brains than found after 6 
days of treatment. These facts suggest that the hor- 
mone acted by accelerating the development of the 
amino acid transport systems so that the 6-day brain 
had transport properties not normally occurring 
until later (i.e., by 10-14 days). Such an action 
should not be unexpected, since thyroid hormone 
has been found to accelerate the rate of develop- 
ment of brain in a number of other ways: e.g., it 
hastens brain cell formation and differentiation 
(Balazs and Richter, 1973; Pelton and Bass, 1973; 
Lauder, 1977), accelerates metabolic maturation of 
the brain (Balazs and Richter, 1973), and increases 
the rate of behavioral development (Schapiro, 1968; 
Schapiro et al., 1970). 
On the other hand, the stimulating action of 'the 
hormone after 14 days appears to result from an 
increased activity of one or both of the systems 
present at that time rather than from a further ac- 
celeration of the development of brain transport 
systems. Normal development beyond 14 days did 
not result in greater uptake than at 14 days; if any- 
thing, it declined. The uptakes of AIB and MeAIB 
were higher in the 14-day hormone-treated tissues 
than in control tissues at any age studied (up to 30 
days) (Figs. 1 and 2). 
The characteristics of the new transport pro- 
duced at 14 days by thyroxine (i.e., the increment, 
uptake after thyroxine treatment minus uptake in 
controls) were different from those found in control 
tissues, a fact suggesting that the hormone did not 
influence both of the 14-day transport systems to 
the same extent. Furthermore, the characteristics 
were not the same for AIB as they were for MeAIB 
(Table 3). The results may be explained if thyroxine 
acts on both of the 14-day systems, but AIB and 
MeAIB have a different quantitative division of 
their transports between the two systems. We have 
shown already that these two amino acids probably 
do not share the same transport systems to the same 
extent in control 14-day-old brain slices (Riggs et 
al., 1984). The characteristics of the increment in 
uptake of MeAIB suggest that most or all of its 
stimulation may involve system A: the increment 
was highly sensitive to "a+], temperature, pH, 
and high levels of the A-system amino acids, 
MeAIB, AIB, and alanine, while affected much less 
by leucine and valine (Table 3, column 6). In con- 
trast, the thyroxine-induced increment in uptake of 
1 mM AIB was not inhibited by 20 mM MeAIB, it 
showed relatively little inhibition by proline, and it 
was much less sensitive to decreased temperature 
and pH than was the increment in MeAIB uptake 
(Table 3, column 3). Uptake of AIB at this level 
would appear, therefore, to be increased by way of 
both system A and the new system it normally uses 
after 6 days. The difference between effects on the 
two amino acids is undoubtedly a consequence of 
a much lower affinity of MeAIB for the new trans- 
port system relative to AIB, as is suggested by the 
much higher level of MeAIB needed before curva- 
ture occurs in the Lineweaver-Burk plots. The re- 
sults may be explained if we conclude that a 1 mM 
level of MeAIB is transported almost entirely by 
system A, while this level of AIB uses both sys- 
tems. A stimulation of the new system by thyroxine 
then would show up when 1 mM AIB was tested, 
but not when 1 mM MeAIB was used. 
The identity of the second thyroxine-sensitive 14- 
day system is not clear from the data. Sershen and 
Lajtha (1979) have distinguished at  least seven 
transport systems in newborn and adult mouse 
brain for the different neutral amino acids. In ad- 
dition to systems A, L, and ASC, other individual 
systems were suggested for transporting y-amino- 
butyric acid, glycine, proline, and taurine. It is pos- 
sible that one of these last four systems is thy- 
roxine-sensitive and used by AIB and MeAIB at 14 
days. The second system is probably not ASC, 
however, since thyroxine treatment for 14 days did 
not alter uptake of alanine (Fig. 2), one of the sub- 
strates originally used to define this system (Chris- 
tensen et al., 1967). System L is a more likely pos- 
sibility. Thyroxine increases transport of leucine, a 
major system L amino acid, at 14 days but not at 6 
days. Furthermore, AIB uses system L at ages be- 
yond 6 days (Riggs et al., 1984), perhaps enough by 
14 days that a 1 mM level responds to a possible 
thyroxine stimulation of this system. 
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